Out-of-pocket costs for name-brand GLP-1 medications like Wegovy or Ozempic can soar above $1,300/month ... and even when it does, prior authorization requirements and surprise fees can cause delays ...

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers ...

After 72 weeks of treatment, people taking Zepbound lost about 50 pounds, compared with 33 pounds for those taking Wegovy. The weight loss drug Zepbound (tirzepatide) led to 50 percent more weight ...

The Boston-based company, which was founded in 2019, aims to fix the inefficiencies and administrative burden associated with the traditional prior authorization process. By streamlining this ...

People who take Wegovy appear to be at greater risk for hair loss, according to an early study that hasn't yet been peer-reviewed. Females in the study were twice as likely to lose hair as males.

Despite its commercial success with blockbuster drugs like Wegovy and Ozempic, Novo faced challenges developing next-generation weight loss drugs amid its fierce rivalry with Eli Lilly. Notably, its ...

New “landmark” data, presented by the manufacturer Novo Nordisk, shows Wegovy can protect against ... a significant amount of weight lost and prior to full semaglutide titration.

Wegovy and Mounjaro, while available through private prescriptions, are not subsidised through the Pharmaceutical Benefits Scheme (PBS) but the TGA has revealed demand for the anti-diabetic drug ...